Predicting the Effect of Renal Function on Systemic Clearance: Is a Simple Scaling Method Sufficient?

Area of Science:

• Pharmacokinetics and Drug Metabolism
• Renal Pharmacology
• Clinical Pharmacology

Background:

• Drug clearance is significantly impacted by renal function, especially for renally eliminated drugs.
• Accurate prediction of drug clearance is crucial for safe and effective dosing in patients with impaired kidney function.
• Existing methods for dose adjustment in renal impairment can be complex or lack generalizability.

Purpose of the Study:

• To develop and validate a simple scaling method for predicting systemic or oral clearance of renally cleared drugs.
• To assess the method's accuracy using fraction of drug eliminated in urine (fe) and a patient's relative renal function (SGFR).

Main Methods:

• A literature-based analysis of 82 drugs with known renal clearance (fe > 0.3) was performed.
• A simple renal function scaler was developed and compared against linear regression models.
• The scaler's predictive performance was evaluated using replicate pharmacokinetic studies.

Main Results:

• The scaling method predicted drug clearance within 50-200% of observed data for 92% of patients with severe kidney disease.
• For drugs with replicate studies, the scaling approach demonstrated comparable or superior predictive accuracy to linear regression.
• The method effectively accounts for variations in creatinine clearance (ClCR) on systemic clearance.

Conclusions:

• A simple, generalizable scaling approach can effectively guide dose adjustments for renally cleared drugs in patients with reduced renal function.
• This method offers advantages for clinical practice and may streamline drug development by facilitating efficient pharmacokinetic study design.